Strain SummarySTOCK E2f3tm5(E2f1)Gle

Strain Name

STOCK E2f3tm5(E2f1)Gle

Strain Type(s)

targeted mutation (knock-in)

Strain Synonym(s)

1+/+3a1KI/1KI  •  3a1KI/1KI  •  E2f1+/+ E2f3a1KI/1KI  •  E2f3a1KI/1KI

Description

Homozygous mice. This STOCK background was a mixture of "FVB/NT" [Note: The "T" may be an erroneous indication of Taconic, lab code "Tac".], "129v/Sv", and "C57BL/Swiss".

Strain Genetics

E2f3tm5(E2f1)Gle / E2f3tm5(E2f1)Gle

Models

5 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Liver adenoma Liver

6.25

4.3

References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842

Liver hepatocellular carcinoma Liver

64

87.5

70

References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842

Liver hepatocellular carcinoma Liver diethylnitrosamine (DEN)

80

100

References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842

Liver tumor Liver

94

observed

References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842

Liver tumor Liver polyinosinic/polycytidylic acid (pIpC) (poly I:C)

observed

References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842